Dark Forest Capital Management’s Kyntra Bio KYNB Stock Holding History

Dark Forest Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$46.8K	–	1156
2023 Q1	$46.8K	Buy	+100	New	+$52.9K	0.01%	855
2022 Q4	–	Sell	-289	Closed	-$94K	–	1255
2022 Q3	$94K	Buy	289 +288	+28,800%	+$92.8K	0.02%	474
2022 Q2	$0	Buy	+1	New	+$255	﹤0.01%	1042
2022 Q1	–	Sell	-41	Closed	-$15K	–	1435
2021 Q4	$15K	Buy	+41	New	+$12.8K	0.01%	772
2021 Q3	–	Sell	-11	Closed	-$7K	–	1348
2021 Q2	$7K	Buy	+11	New	+$6.34K	﹤0.01%	668

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dark Forest Capital Management's KYNB Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 100 shares — an estimated $46.8K sold.

Dark Forest Capital Management first reported a position in KYNB in Q2 2021 and held it in 5 quarters. The position peaked at $94K in Q3 2022. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

Dark Forest Capital Management reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
Dark Forest Capital Management sold 100 Kyntra Bio shares in Q2 2023, an estimated $46.8K.
Dark Forest Capital Management first reported a position in Kyntra Bio in Q2 2021 and held it in 5 quarters.
Dark Forest Capital Management's Kyntra Bio position peaked at $94K in Q3 2022.
152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.